ShiraniAOkudaDTStüveO. Therapeutic advances and future prospects in progressive forms of multiple sclerosis. Neurotherapeutics2016; 13: 58–69.
3.
Paz SoldánMMNovotnaMAbou ZeidN. Relapses and disability accumulation in progressive multiple sclerosis. Neurology2015; 84: 81–88.
4.
PaltamaaJSjögrenTPeuralaSH. Effects of physiotherapy interventions on balance in multiple sclerosis: A systematic review and meta-analysis of randomized controlled trials. J Rehabil Med2012; 44: 811–823.
5.
DalgasUStenagerE. Exercise and disease progression in multiple sclerosis: Can exercise slow down the progression of multiple sclerosis?Ther Adv Neurol Disord2012; 5: 81–95.
6.
KhederANairKP. Spasticity: Pathophysiology, evaluation and management. Pract Neurol2012; 12: 289–298.
7.
AlusiSHWorthingtonJGlickmanS. A study of tremor in multiple sclerosis. Brain2001; 124: 720–730.
8.
BemelmansBLHommesORVan KerrebroeckPE. Evidence for early lower urinary tract dysfunction in clinically silent multiple sclerosis. J Urol1991; 145: 1219–1224.
9.
ÇetinelBTarcanTDemirkesenO. Management of lower urinary tract dysfunction in multiple sclerosis: A systematic review and Turkish consensus report. Neurourol Urodyn2013; 32: 1047–1057.
10.
MohrDCBoudewynACGoodkinDE. Comparative outcomes for individual cognitive-behavior therapy, supportive-expressive group psychotherapy, and sertraline for the treatment of depression in multiple sclerosis. J Consult Clin Psychol2001; 69: 942–949.